Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oligosaccharide Assembly01:24

Oligosaccharide Assembly

3.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.8K
Protein Glycosylation01:25

Protein Glycosylation

10.2K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-132 overexpression is associated with modulation in miR-21 expression and glioblastoma cell behavior.

PloS one·2026
Same author

Optimization of keratinase production by <i>Bacillus cereus</i> HD1 using feather waste and its laboratory scale validation in bioreactor with oxygen and carbon supplementation.

Preparative biochemistry & biotechnology·2026
Same author

Overexpression of histidine decarboxylase promotes cancer cell apoptosis and migration in HN5 cells.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains.

Scientific reports·2025
Same author

Catalytically active inclusion bodies of cold-adapted lipase: production and its industrial potential.

AMB Express·2025
Same author

Immobilized inclusion bodies of recombinant cold-adaptive lipase from Antarctic Pseudomonas sp. as catalysts.

Applied microbiology and biotechnology·2025

Related Experiment Video

Updated: Mar 12, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.9K

Humanizing glycosylation pathways in eukaryotic expression systems.

Amjad Hayat Khan1, Hadi Bayat2,3, Masoumeh Rajabibazl4,5

  • 1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran.

World Journal of Microbiology & Biotechnology
|November 13, 2016
PubMed
Summary

Glycosylation, a key protein modification, impacts therapeutic glycoprotein function. This review explores strategies for humanizing glycosylation in expression hosts and highlights Leishmania as a promising system.

Keywords:
Eukaryotic expression systemsGlycoengineeringGlycosylation patternLEXSY

More Related Videos

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

32.0K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

13.3K

Related Experiment Videos

Last Updated: Mar 12, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.9K
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

32.0K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

13.3K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Glycosylation is a prevalent posttranslational modification impacting protein properties.
  • Therapeutic glycoproteins require specific glycosylation for efficacy.
  • Existing expression systems have limitations in achieving human-like glycosylation.

Purpose of the Study:

  • To review strategies for humanizing glycosylation pathways in expression hosts.
  • To highlight the potential of protozoan parasites, specifically Leishmania tarentolae, as a mammalian-like glycosylation expression system.

Main Methods:

  • Literature review of glycosylation strategies in various expression systems.
  • Analysis of glycosylation pathways in eukaryotic hosts.
  • Evaluation of Leishmania tarentolae's glycosylation capabilities.

Main Results:

  • Eukaryotic expression systems often produce non-human glycosylation patterns.
  • Various strategies exist to engineer glycosylation pathways for humanization.
  • Leishmania tarentolae exhibits mammalian-like glycosylation, offering a novel expression system.

Conclusions:

  • Engineering glycosylation pathways is crucial for producing effective therapeutic glycoproteins.
  • Leishmania expression systems present a viable alternative for achieving human-like glycosylation.